ASTA Contends Risk Profile Overstates Risk of Spices
ASTA submitted extensive comments and a scientific review of the FDA’s Draft Risk Profile on Pathogens and Filth in Spices. These comments will now be reviewed by FDA and considered as the risk profile is finalized.